Liquidia Shares Climb 27% After Settlement Resolves Pending Litigation
Image: TokenPost
Liquidia Corporation (LQDA) shares rose nearly 27% on Oct. 14 after the company reached a settlement with United Therapeutics that resolves pending litigation between the companies. The stock closed at $33.94, up $7.13 from its previous close. The settlement resolves all pending litigation between the companies. Enna Lee reports on investing and digital-asset markets for TokenPost. Send corrections or tips to info@tokenpost.com.
Read the full story on TokenPostBeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.
